SARACENO, GIOVANNA
 Distribuzione geografica
Continente #
NA - Nord America 641
EU - Europa 590
AS - Asia 250
SA - Sud America 3
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.486
Nazione #
US - Stati Uniti d'America 641
IE - Irlanda 193
SE - Svezia 176
CN - Cina 150
SG - Singapore 76
DE - Germania 47
IT - Italia 44
FI - Finlandia 28
GB - Regno Unito 21
UA - Ucraina 20
IN - India 17
AT - Austria 14
PL - Polonia 13
CH - Svizzera 10
FR - Francia 7
CZ - Repubblica Ceca 6
ES - Italia 5
BE - Belgio 3
KR - Corea 2
NL - Olanda 2
VN - Vietnam 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CL - Cile 1
CO - Colombia 1
EC - Ecuador 1
EG - Egitto 1
ID - Indonesia 1
PH - Filippine 1
RU - Federazione Russa 1
TR - Turchia 1
Totale 1.486
Città #
Dublin 193
Chandler 123
Nyköping 107
Jacksonville 67
Singapore 67
Beijing 48
New York 42
Ashburn 39
Dearborn 31
Princeton 29
Cambridge 27
Des Moines 24
Medford 20
Munich 17
Ann Arbor 15
Jinan 15
Lancaster 14
Mountain View 14
Bad Aussee 13
Boardman 13
Nanjing 13
Woodbridge 12
Ningbo 11
Shenyang 10
Warsaw 10
Villamagna 9
San Mateo 8
Tianjin 8
Wilmington 7
Brno 6
Cosenza 5
Hyderabad 5
Jiaxing 5
Messina 5
Seattle 5
Bremen 4
Fuzhou 4
Hebei 4
Pittsburgh 4
Pune 4
Taizhou 4
Zhengzhou 4
Aci Castello 3
Brussels 3
Changsha 3
Chennai 3
Guangzhou 3
Mumbai 3
Nanchang 3
Taiyuan 3
la Garriga 3
Dallas 2
Dong Ket 2
East Brunswick 2
Haikou 2
Hangzhou 2
Houston 2
Lodz 2
Los Angeles 2
Norwalk 2
Roccascalegna 2
Sabadell 2
San Antonio 2
Seongnam-si 2
Solon 2
Albany 1
Amstelveen 1
Angeles City 1
Bengaluru 1
Bursa 1
Cagliari 1
Cairo 1
Changle 1
Chicago 1
Clifton 1
Darmstadt 1
Helsinki 1
Jakarta 1
Kemerovo 1
L'hay-les-roses 1
London 1
Lublin 1
Milan 1
Napoli 1
Nürnberg 1
Qingdao 1
Quito 1
Redwood City 1
Riva 1
Rome 1
Saint Paul 1
San Gregorio 1
Washington 1
Totale 1.148
Nome #
Coffee impairs intestinal absoprtion of levo-thyroxine: report of additional cases. 94
Coffee Impairs Intestinal Absorbtion of Levothyroxine: Report of Additional Cases 84
Additional cases of impairment of L-thyroxine (L-T4) intestinal absorption caused by coffee. 79
A minimum of two years of undertreated primary hypothyroidism, as a result of drug-induced malabsorption of L-thyroxine, may have metabolic and cardiovascular consequences 79
A novel formulation of L-thyroxine (L-T4) solves problems of L-T4 malabsorption caused by coffee in patients under replacement or TSH suppressive L-T4 therapy with conventional tablets. 70
Interference of L-T4 absorption by proton-pump inhibitors (PPIs) can be solved by a liquid ormulation of L-thyroxine (L-T4). 69
A liquid formulation of L-thyroxine (L-T4) solves problems of incomplete normalization/suppression of serum TSH caused by proton pump inhibitors (PPI) on conventional tablet formulations of L-T4. 68
Altered intestinal absorption of L-thyroxine caused by coffee. 66
Ricerca della mutazione BRAF V600E su citoaspirato ecoguidato dei noduli tiroidei in pazienti dell'area dello Stretto. 65
FOLLICULAR VARIANT OF PAPILLARY THYROID CARCINOMA PRESENTING AS A TOXIC NODULE IN AN ADOLESCENT GIRL 58
BIOINFORMATICS SUPPORT THE POSSIBLE TRIGGERING OF AUTOIMMUNE THYROID DISEASES BY YERSINIA ENTEROCOLITICA OUTER MEMBRANE PROTEINS HOMOLOGOUS TO THE HUMAN TSH RECEPTOR 56
In patients with no interference on the intestinal absorption of L-T4 caused by gastro-intestinal disorders or drugs, a liquid formulation of L-T4 permits to reach target TSH levels that were missed by the conventional tablet formulation. 54
Dati bioinformatici a supporto del possibile scatenamento di malattie autoimmuni tiroidee (MAIT) da parte di "outer membrane proteins" (OMP) di Yesrinia enterocolitica (Ye) aventi omologia di sequenza col recettor eumano del TSH (TSHR). 53
Follicular variant of papillary thyroid carcinoma presenting as toxic nodule in an adolescent: coexistent polymorphism of the TSHR and Gsα genes 50
Two novel formulations of L-T4 (oral solution and soft gel capsule) are refractory to the coffee-induced intestinal malabsorption of tablet LT4. 50
Una nuova formulazione di L-T4 risolve il problema del malassorbimento intestinale da caffè della L-T4. 48
Urticaria and thyroid autoimmunity 48
A novel formulation of l-thyroxine (l-T4) reduces the problem of l-T4 malabsorption by coffee observed with traditional tablet formulations 47
L'interferenza dell'assorbimento della L-tiroxina (L-T4) da parte degli inibitori di pompa protonica (PPI) può essere risolta da una formulazione liquida di L-T4. 46
Dati bioinformatici a supporto del possibile scatenamento di malattie autoimmuni tiroidee da parte di “outer membrane proteins”di Yersinia enterocolitica aventi omologia di sequenza col recettore umano del TSH. 44
Intranuclear cytoplasmic inclusions in cytologically suspicious or malignant thyroid nodules: identification and correlation with echogenicity and size of the nodules. 44
Switching Levothyroxine from the tablet to the oral solution formulation corrects the impaired absorption of Levothyroxine induced by proton-pump inhibitors. 42
FOLLICULAR VARIANT OF PAPILLARY THYROID CARCINOMA PRESENTING AS A TOXIC NODULE IN AN ADOLESCENT GIRL. 41
Intranuclear cytoplasmic inclusions in cytologically suspicious or malignant nodules: correlation with echo texture and size of the nodules. 40
New targeted therapies for anaplastic thyroid cancer. 34
Increased CXCL9 Serum Levels in Hepatitis C-Related Mixed Cryoglobulinemia, with Autoimmune Thyroiditis, Associated with High Levels of CXCL10 30
Refractoriness of two novel formulations of L-T4 (oral solution and soft gel capsule) to the coffee-induced intestinal absorption of tablet L-T4. 28
Occult leydig cell tumour and androgen-receptor positive breast cancer in a woman with severe hyperandrogenism. 23
Totale 1.510
Categoria #
all - tutte 6.244
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.244


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020150 0 0 0 0 1 32 19 29 2 35 31 1
2020/2021132 10 0 38 9 18 16 4 6 2 8 12 9
2021/2022213 0 29 2 13 10 0 39 6 1 23 36 54
2022/2023518 51 53 22 28 35 56 3 36 220 1 10 3
2023/2024193 12 16 30 8 22 63 0 7 0 9 3 23
2024/2025107 18 4 4 45 36 0 0 0 0 0 0 0
Totale 1.510